Oratox

Product NDC
43742-0170
11-digit product format
437420170
Labeler code
43742
Product ID
43742-0170_e663e2c9-af1c-44e5-a472-ca5fb62ab93d
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
Fucus Vesiculosus, Lymph Node, Medulla Ossis Suis, Thymus, Thyroidinum, Calcarea Muriatica, Iodium, Natrum Fluoratum, Natrum Muriaticum, Selenium Metallicum, Vanadium Metallicum, Argentum Metallicum, Aurum Metallicum, Cuprum Metallicum, Eugenol, Formalinum, Lidocaine, Mercurius Solubilis, Molybdenum Metallicum, Niccolum Metallicum, Palladium Metallicum, Stannum Metallicum, Titanium Metallicum, Zincum Metallicum,
Dosage form
LIQUID
Route
ORAL
Labeler
Deseret Biologicals, Inc.
Marketing category
UNAPPROVED HOMEOPATHIC
Marketing start
2012-10-31
Marketing end
2020-12-02
Substance
FUCUS VESICULOSUS; SUS SCROFA LYMPH; SUS SCROFA BONE MARROW; SUS SCROFA THYMUS; SUS SCROFA THYROID; CALCIUM CHLORIDE; IODINE; SODIUM FLUORIDE; SODIUM CHLORIDE; SELENIUM; VANADIUM; SILVER; GOLD; COPPER; EUGENOL; FORMALDEHYDE; LIDOCAINE; MERCURIUS SOLUBILIS; MOLYBDENUM; NICKEL; PALLADIUM; TIN; TITANIUM; ZINC
Active strength
3 [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL
Pharmacologic classes
Blood Coagulation Factor [EPC],Increased Coagulation Factor Activity [PE],Calcium [CS],Cations, Divalent [CS],Osmotic Laxative [EPC],Increased Large Intestinal Motility [PE],Inhibition Large Intestine Fluid/Electrolyte Absorption [PE],Osmotic Activity [MoA],Standardized Chemical Allergen [EPC],Increased Histamine Release [PE],Allergens [CS],Cell-mediated Immunity [PE],Copper [CS],Copper-containing Intrauterine Device [EPC],Decreased Embryonic Implantation [PE],Decreased Sperm Motility [PE],Inhibit Ovum Fertilization [PE],Standardized Chemical Allergen [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Allergens [CS],Standardized Chemical Allergen [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Allergens [CS],Amide Local Anesthetic [EPC],Amides [CS],Antiarrhythmic [EPC],Local Anesthesia [PE],Standardized Chemical Allergen [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Allergens [CS]
NDC exclude flag
No
Listing certified through
0000-00-00
Current FDA listing
Historical FDA.report record